178 related articles for article (PubMed ID: 19752716)
1. Crack cocaine use increases the incidence of AIDS-defining events in French Guiana.
Nacher M; Adenis A; Hanf M; Adriouch L; Vantilcke V; El Guedj M; Vaz T; Dufour J; Couppié P
AIDS; 2009 Oct; 23(16):2223-6. PubMed ID: 19752716
[TBL] [Abstract][Full Text] [Related]
2. Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users.
Baum MK; Rafie C; Lai S; Sales S; Page B; Campa A
J Acquir Immune Defic Syndr; 2009 Jan; 50(1):93-9. PubMed ID: 19295339
[TBL] [Abstract][Full Text] [Related]
3. Increased incidence of leprosy following HAART initiation: a manifestation of the immune reconstitution disease.
Couppié P; Domergue V; Clyti E; El Guedj M; Vaz T; Sainte-Marie D; Marty C; Nacher M
AIDS; 2009 Jul; 23(12):1599-600. PubMed ID: 19487911
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors of herpes zoster HIV-infected patients: another adverse effect of crack cocaine.
Nacher M; Basurko C; Adenis A; Gaubert-Marechal E; Mosnier E; Edouard S; Vantilcke V; Sivapregassam S; Tressières B; Cabié A; Couppié P
PLoS One; 2013; 8(11):e80187. PubMed ID: 24244647
[TBL] [Abstract][Full Text] [Related]
5. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection.
Selwyn PA; Alcabes P; Hartel D; Buono D; Schoenbaum EE; Klein RS; Davenny K; Friedland GH
N Engl J Med; 1992 Dec; 327(24):1697-703. PubMed ID: 1359411
[TBL] [Abstract][Full Text] [Related]
6. [Dermatologic manifestations associated with immune reconstitution syndrome in HIV+ patients starting HAART: a retrospective study in French Guiana].
Sarazin E; Nacher M; Toure Y; Clyti E; El Guedj M; Aznar C; Vaz T; Sainte-Marie D; Sobesky M; Carme B; Couppié P
Bull Soc Pathol Exot; 2005 Sep; 98(3):187-92. PubMed ID: 16267958
[TBL] [Abstract][Full Text] [Related]
7. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.
Gandhi T; Wei W; Amin K; Kazanjian P
Clin Infect Dis; 2006 Mar; 42(6):878-84. PubMed ID: 16477568
[TBL] [Abstract][Full Text] [Related]
8. Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women.
Cook JA; Burke-Miller JK; Cohen MH; Cook RL; Vlahov D; Wilson TE; Golub ET; Schwartz RM; Howard AA; Ponath C; Plankey MW; Levine AM; Grey DD
AIDS; 2008 Jul; 22(11):1355-63. PubMed ID: 18580615
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 prevalence and risk factors among sexually transmitted disease clinic attenders in Trinidad.
Cleghorn FR; Jack N; Murphy JR; Edwards J; Mahabir B; Paul R; White F; Bartholomew C; Blattner WA
AIDS; 1995 Apr; 9(4):389-94. PubMed ID: 7794544
[TBL] [Abstract][Full Text] [Related]
10. Predictors of crack cocaine initiation among Montréal street youth: a first look at the phenomenon.
Paquette C; Roy E; Petit G; Boivin JF
Drug Alcohol Depend; 2010 Jul; 110(1-2):85-91. PubMed ID: 20303221
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a prospective observational study.
Hung CC; Chen MY; Hsieh SM; Hsiao CF; Sheng WH; Chang SC
Vaccine; 2004 May; 22(15-16):2006-12. PubMed ID: 15121313
[TBL] [Abstract][Full Text] [Related]
12. AIDS knowledge and risk perception of cocaine and crack users in a national household survey.
Silbersiepe KA; Hardy AM
AIDS Educ Prev; 1997 Oct; 9(5):460-71. PubMed ID: 9391660
[TBL] [Abstract][Full Text] [Related]
13. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
14. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
[TBL] [Abstract][Full Text] [Related]
15. Increased incidence of mucosal candidiasis after HAART initiation: a benign form of immune reconstitution disease?
Nacher M; Vantilcke V; Huber F; Mahamat A; El Guedj M; Randrianjohany A; Clyti E; Aznar C; Carme B; Couppié P
AIDS; 2007 Nov; 21(18):2534-6. PubMed ID: 18025892
[TBL] [Abstract][Full Text] [Related]
16. Risk of human immunodeficiency virus infection among pregnant crack cocaine users in a rural community.
Ellerbrock TV; Harrington PE; Bush TJ; Schoenfisch SA; Oxtoby MJ; Witte JJ
Obstet Gynecol; 1995 Sep; 86(3):400-4. PubMed ID: 7651651
[TBL] [Abstract][Full Text] [Related]
17. Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000-2004.
Bonnet F; Chêne G; Thiébaut R; Dupon M; Lawson-Ayayi S; Pellegrin JL; Dabis F; Morlat P;
HIV Med; 2007 Nov; 8(8):547-54. PubMed ID: 17944688
[TBL] [Abstract][Full Text] [Related]
18. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
[TBL] [Abstract][Full Text] [Related]
19. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS
Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787
[TBL] [Abstract][Full Text] [Related]
20. Associations between use of crack cocaine and HIV-1 disease progression: research findings and implications for mother-to-infant transmission.
Cook JA
Life Sci; 2011 May; 88(21-22):931-9. PubMed ID: 21219914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
